Celebrating Two Decades of Progress in Gastric and Esophageal Cancer Research The DeGregorio Family Foundation marks its 20th anniversary supporting research for gastric and esophageal cancers with nearly $10 million in grants.

Celebrating Two Decades of Progress in Gastric and Esophageal Cancer Research #USA #New_York #gastric_cancer #Esophageal_Cancer #DeGregorio_Foundation

Lucid Diagnostics Reveals Breakthrough in Esophageal Precancer Detection with Largest Real-World Study Results Lucid Diagnostics has announced impressive results from a large-scale study on esophageal precancer detection, confirming the effectiveness of their non-invasive testing methods.

Lucid Diagnostics Reveals Breakthrough in Esophageal Precancer Detection with Largest Real-World Study Results #USA #New_York #Lucid_Diagnostics #Esophageal_Cancer #Lucida

Lucid Diagnostics Reveals Plans For New Public Stock Offering to Boost Cancer Detection Efforts Lucid Diagnostics has announced its intention to offer common stock in a public offering to enhance its cancer prevention capabilities. Major underwriters will assist in the process.

Lucid Diagnostics Reveals Plans For New Public Stock Offering to Boost Cancer Detection Efforts #United_States #New_York #Lucid_Diagnostics #Esophageal_Cancer #PAVmed_Inc

Hoag Digestive Health Institute Unveils Innovative Esophageal Cancer Screening Tool to Save Lives Hoag Digestive Health Institute launches EsoGuard, a groundbreaking, non-invasive tool for early detection of esophageal cancer, revolutionizing patient care.

Hoag Digestive Health Institute Unveils Innovative Esophageal Cancer Screening Tool to Save Lives #United_States #Newport_Beach #EsoGuard #Esophageal_Cancer #Hoag_Digestive_Health

Lucid Diagnostics to Join Russell Indexes—A Milestone for Cancer Detection Innovation Lucid Diagnostics has announced its addition to the Russell 2000 and Russell 3000 Indexes. This significant achievement signals growth in cancer detection innovation and potential investment opportunities.

Lucid Diagnostics to Join Russell Indexes—A Milestone for Cancer Detection Innovation #United_States #New_York #Lucid_Diagnostics #Esophageal_Cancer #PAVmed

Lucid Diagnostics Unveils Innovative Campaign Focused on EsoCheck's Life-Saving Technology for Esophageal Cancer Prevention Lucid Diagnostics has launched a campaign to promote EsoCheck's revolutionary cell collection technology amid Esophageal Cancer Awareness Month, enhancing early detection efforts.

Lucid Diagnostics Unveils Innovative Campaign Focused on EsoCheck's Life-Saving Technology for Esophageal Cancer Prevention #United_States #New_York #Lucid_Diagnostics #Esophageal_Cancer #EsoCheck

Lucid Diagnostics Achieves Critical Publication on EsoGuard® for Esophageal Precancer Testing Lucid Diagnostics announces the acceptance of their ENVET-BE study for peer-reviewed publication, demonstrating EsoGuard®'s efficacy in esophageal precancer detection.

Lucid Diagnostics Achieves Critical Publication on EsoGuard® for Esophageal Precancer Testing #USA #New_York #Lucid_Diagnostics #EsoGuard #Esophageal_Cancer

Tract Bio's Innovative Research Offers New Insights into Esophageal Adenocarcinoma Therapeutics Tract Bio's recent publication unveils potential therapeutic targets for esophageal adenocarcinoma through their advanced stemECHO cloning platform, offering hope for new cancer treatments.

Tract Bio's Innovative Research Offers New Insights into Esophageal Adenocarcinoma Therapeutics #USA #Boston #Esophageal_Cancer #Tract_Bio #stemECHO

Major Expansion in Esophageal Cancer Detection Coverage Reaches 73 Million Lives CDx Diagnostics announces a significant expansion of its WATS3D solution's insurance coverage, bringing it to 73 million lives, enhancing early esophageal cancer detection.

Major Expansion in Esophageal Cancer Detection Coverage Reaches 73 Million Lives #United_States #WATS3D #Esophageal_Cancer #CDx_Diagnostics #Suffern

Lucid Diagnostics and VITALExam Join Forces to Combat Esophageal Precancer in Firefighters Lucid Diagnostics partners with VITALExam to improve esophageal cancer screening among firefighters, prioritizing their health and safety.

Lucid Diagnostics and VITALExam Join Forces to Combat Esophageal Precancer in Firefighters #United_States #Lucid_Diagnostics #Esophageal_Cancer #VITALExam #Tuscaloosa,_Alabama

Lucid Diagnostics EsaGuard Test's Clinical Utility Study Accepted for Peer Review Publication: A Major Step Forward in Esophageal Cancer Screening The EsoGuard Esophageal DNA Test by Lucid Diagnostics is validated through a new clinical study showcasing impressive patient compliance rates and effectiveness in esophageal cancer screening.

Lucid Diagnostics EsaGuard Test's Clinical Utility Study Accepted for Peer Review Publication: A Major Step Forward in Esophageal Cancer Screening #USA #New_York #Lucid_Diagnostics #EsoGuard #Esophageal_Cancer